Kyriakos Souliotis, Christina Golna, Chara Kani, Sofia Nikolaidi, Dimitrios Boumpas Introduction: Rheumatoid Arthritis (RA) is a highly prevalent autoimmune disease associated with joint inflammation and destruction. Treatment for RA, especially with biologic agents (biologics), improves patient functionality and quality of life and averts costly complications or disease progression. Cost of RA pharmaceutical treatment has rarely been reported on the basis…
